Insider holders · CIK 0001510487
Principia Biopharma Inc. · PRNB
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Simeon GeorgeDirector | — | 2,625,713 | 2,625,713 | Sep 20, 2018 · 6:50 pm EDT | Form 4 |
| GLAXOSMITHKLINE PLC10% Owner | — | 2,625,713 | 2,625,713 | Sep 20, 2018 · 5:18 pm EDT | Form 4 |
| OrbiMed Capital GP IV LLC10% Owner | — | 2,605,713 | 2,605,713 | Sep 20, 2018 · 6:59 pm EDT | Form 4 |
| ORBIMED ADVISORS LLC10% Owner | — | 2,605,713 | 2,605,713 | Sep 20, 2018 · 6:59 pm EDT | Form 4 |
| Anand Mehra10% Owner | 2,038,208 | — | 2,038,208 | Sep 20, 2018 · 7:02 pm EDT | Form 4 |
| Sofinnova Management VIII, L.L.C.10% Owner | 2,038,208 | — | 2,038,208 | Sep 20, 2018 · 7:02 pm EDT | Form 4 |
| Sofinnova Venture Partners VIII, L.P.10% Owner | 2,038,208 | — | 2,038,208 | Sep 20, 2018 · 7:02 pm EDT | Form 4 |
| James Healy10% Owner | 2,038,208 | — | 2,038,208 | Sep 20, 2018 · 7:02 pm EDT | Form 4 |
| Michael Powell10% Owner | 2,038,208 | — | 2,038,208 | Sep 20, 2018 · 7:02 pm EDT | Form 4 |
| Daniel J. BeckerDirector | — | 437,537 | 437,537 | Sep 20, 2018 · 6:58 pm EDT | Form 4 |
| New Leaf BPO Associates II, L.P.10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| New Leaf BPO Management II, L.L.C10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| New Leaf Biopharma Opportunities II, L.P.10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| New Leaf Venture Associates II, L.P.10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| New Leaf Venture Management II, L.L.C.10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| New Leaf Ventures II, L.P.10% Owner | — | 437,537 | 437,537 | Sep 20, 2018 · 6:53 pm EDT | Form 4 |
| Srinivas AkkarajuDirector | — | 383,480 | 383,480 | Sep 20, 2018 · 4:14 pm EDT | Form 4 |
| Roy C. HardimanChief Business Officer | 117,202 | 1,376 | 118,578 | Sep 13, 2018 · 5:05 pm EDT | Form 3 |
| Steve GourlayChief Medical Officer | 107,857 | — | 107,857 | Sep 20, 2018 · 6:47 pm EDT | Form 4 |
| Martin BablerChief Executive Officer | — | 79,179 | 79,179 | Sep 20, 2018 · 6:45 pm EDT | Form 4 |
| Stefani WolffSenior VP of Strategy and Ops | 32,668 | — | 32,668 | Sep 13, 2018 · 5:07 pm EDT | Form 3 |
| David GoldsteinChief Scientific Officer | 28,027 | — | 28,027 | Sep 13, 2018 · 5:06 pm EDT | Form 3 |
| Christopher Y ChaiChief Financial Officer | 6,825 | 1,651 | 8,476 | Sep 13, 2018 · 5:03 pm EDT | Form 3 |
| Peter A. ThompsonDirector | 3,945 | — | 3,945 | Sep 13, 2018 · 5:14 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.